EE232 Impact of Updated Mortality Estimates on the Cost-Effectiveness of Rifaximin for the Treatment of Patients with Overt Hepatic Encephalopathy
Abstract
Authors
S. Bhattacharyya D. John A. Thomas P. Soni A.B. Jesudian A.A. Dashputre G. Joseph